Prospective cohort study evaluates quality of life changes after pancreatic surgery, highlighting recovery trends.
Introduction ancreaticoduodenectomy for periampullary tumors is a complex surgery with potential complications and long recovery, impacting patients' quality of life (QoL). This study evaluates QoL changes from preoperative status to 12 months post-surgery. Methods prospective cohort study was conducted at the University Medical Center of Ho Chi Minh City from January 2019 to May 2021. Patients undergoing pancreaticoduodenectomy (laparoscopic or open) were assessed using the SF-36 questionnaire at baseline, 1, 3, 6 and 12 months post-discharge. Exclusion criteria included total pancreatectomy, in-hospital mortality and disease recurrence. Data on demographics, comorbidities, tumor staging, complications and survival were analyzed using SPSS 20.0, with paired Wilcoxon tests and regression models. Results mong 111 patients (64 males, mean age 57 ± 12.2 years), 44 had pancreatic head cancer and 21 had ampullary cancer. Laparoscopic surgery was performed in 66 cases. Postoperative fistulas occurred in 30.6%, with one severe case. Median hospital stay was 11 ± 5 days, and average disease-free survival was 20.42 ± 13.4 months. QoL declined at 1 month post-surgery (Physical: 67.29 to 54.69, p = 0.04; and Emotional limitations: 70.17 to 54.18, p = 0.01) but improved from 3 months onward, surpassing pre-treatment levels. Malignancy, comorbidities, cholangitis and postoperative complications negatively impacted QoL. Conclusion oL decreases initially after pancreaticoduodenectomy but stabilizes and improves after 3 months. Preoperative and postoperative management of risk factors may enhance recovery and QoL outcomes.
No takes yet. Share an insight, caveat, or question.
Le et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: